Effects of storage solutions on the viability of human umbilical cord mesenchymal stem cells for transplantation

Cell Transplantation

Volumn 22, Issue 6, 2013, Pages 1075-1086

  Chen, Yan ^a   Yu, Baofeng ^a   Xue, Guofang ^a   Zhao, Jie ^a   Li, Ren Ke ^a,b   Liu, Zhuola ^a   Niu, Bo ^a,c  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

^c CAPITAL INSTITUTE OF PEDIATRICS   (China)

Author keywords

Cell survival; Effect; Storage solutions; Transplantation; Umbilical cord mesenchymal stem cells

Indexed keywords

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL STORAGE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; OSMOLARITY; PRIORITY JOURNAL; ROOM TEMPERATURE; STORAGE; UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; ORGAN PRESERVATION SOLUTIONS; PHENOTYPE; UMBILICAL CORD;

EID: 84877710457     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657602     Document Type: Article

References (45)

1. Ball, L. M.; Bernardo, M. E.; Roelofs, H.; Lankester, A.; Cometa, A.; Egeler, R. M.; Locatelli, F.; Fibbe, W. E. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stemcell transplantation. Blood 110(7):2764-2767; 2007.
2. Centeno, C. J.; Busse, D.; Kisiday, J.; Keohan, C.; Freeman, M.; Karli, D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 11(3): 343-353; 2008.
3. Cramer, C.; Freisinger, E.; Jones, R. K.; Slakey, D. P.; Dupin, C. L.; Newsome, E. R.; Alt, E. U.; Izadpanah, R. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev. 19(12):1875-1884; 2010.
4. Dash, N. R.; Dash, S. N.; Routray, P.; Mohapatra, S.; Mohapatra, P. C. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow derived mesenchymal stem cells. Rejuvenation Res. 12(5): 359-366; 2009.
5. da Silva Meirelles, L.; Chagastelles, P. C.; Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119:2204-2213; 2006.
6. Deuse, T.; Stubbendorff, M.; Tang-Quan, K.; Phillips, N.; Kay, M. A.; Eiermann, T.; Phan, T. T.; Volk, H. D.; Reichenspurner, H.; Robbins, R. S.; Schrepfer, S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 20(5):655-667; 2011.
7. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.J.; Horwitz, E. Minimal criteria for defining multipotentmesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4): 315-317; 2006.
8. Grein, T. A., Freimark, D.; Weber, C.; Hudel, K.; Wallrapp, C.; Czermak, P. Alternatives to dimethylsulfoxide for serumfree cryopreservation of human mesenchymal stem cells. Int. J. Artif. Organs 33(6):370-380; 2010.
9. Guhathakurta, S., Subramanyan, U. R.; Balasundari, R.; Das, C. K.; Madhusankar, N.; Cherian, K. M. Stem cell experiments and initial clinical trial of cellular cardiomyoplasty. Asian Cardiovasc. Thorac. Ann. 17(6):581-586; 2009.
10. Guidance for industry. Potency tests for cellular and gene therapy products. Rockville (MD): Center for Biologics Evaluation and Research (CBER); 20Available from:http://www.federalregister.gov/articles/2011/02/16/2011-3462/guidance-for-industry-potency-tests-for-cellular-and-genetherapy-products-availability.
11. Han, Z. C. Umbilical cord mesenchymal stem cells (UC-MSC: Biology, banking and clinical applications). Bull. Acad. Natl. Med. 193(3):545-547; 2009.
12. Hare, J. M.; Traverse, J. H.; Henry, T. D.; Dib, N.; Strumpf R. K.; Schulman, S. P.; Gerstenblith, G.; DeMaria, A. N.; Denktas, A. E.; Gammon, R. S.; Hermiller, Jr., J. B.; Reisman, M. A.; Schaer, G. L.; Scherman, W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54(24):2277-2286; 2009.
13. Hermann, A.; List, C.; Habisch, H. J.; Vukicevic, V.; Ehrhart-Bornstein, M.; Brenner, R.; Bernstein, P.; Fickert, S.; Storch, A. Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: Limitations for autologous cell replacement strategies. Cytotherapy 12(1):17-30; 2010.
14. Ikehara, S. A new bone marrow transplantation method for stem cell disorders. Ann N. Y. Acad. Sci. 1173:774- 780; 2009.
15. Kadam, S. S.; Tiwari, S.; Bhonde, R. R. Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. In Vitro Cell Dev. Biol. Anim. 45(1-2):23-27; 2009.
16. Krampera, M.; Sartoris, S.; Liotta, F.; Pasini, A.; Angeli, R.; Cosmi, L.; Andreini, A.; Mosna, F.; Bonetti, B.; Rebellato, E.; Testi, M. G.; Frosali, F.; Pizzolo, G.; Tridente, G.; Maggi, E.; Romagnani, S.; Annunziato, F. Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev. 16(5):797-810; 2007.
17. Lane, T. A.; Garls, D.; Mackintosh, E.; Kohli, S.; Cramer, S. C. Liquid storage of marrow stromal cells. Transfusion 49(7):1471-1481; 2009.
18. Le Blanc, K., Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringdén, O.; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371(9624):1579-1586; 2008.
19. Li, G.; Zhang, X. A.; Wang, H.; Wang, X.; Meng, C. L.; Chan, C. Y.; Yew, D. T.; Tsang, K. S.; Li, K.; Tsai, S. N.; Ngai, S. M.; Han, Z. C.; Lin, M. C.; He, M. L.; Kung, H. F. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: Implication in the migration. Proteomics 9(1):20-30; 2009.
20. Liu, Y.; Mu, R.; Wang, S.; Long, L.; Liu, X.; Li, R.; Sun, J.; Guo, J.; Zhang, X.; Guo, J.; Yu, P.; Li, C.; Liu, X.; Huang, Z.; Wang, D.; Li, H.; Gu, Z.; Liu, B.; Li, Z. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res. Ther. 12(6):R210; 2010.
21. Lo, T.; Ho, J. H.; Yang, M. H.; Lee, O. K. Glucose reduction prevents replicative senescence and increases mitochondrial respiration in human mesenchymal stem cells. Cell Transplant. 20(6):813-825; 2011.
22. Low, C. B.; Liou, Y. C.; Tang, B. L. Neural differentiation and potential use of stem cells from the human umbilical cord for central nervous system transplantation therapy. J. Neurosci. Res. 86(8):1670-1679; 2008.
23. Matejtschuk, P.; Dash, C. H.; Gascoigne, E. W. Production of human albumin solution: A continually developing colloid. Br. J. Anaesth. 85(6):887-895; 2000.
24. Matthay, M. A.; Thompson, B. T.; Read, E. J.; McKenna Jr., D. H.; Liu, K. D.; Calfee, C. S.; Lee, J. W. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 138(4):965-972; 2010.
25. Menasche, P. Cardiac cell therapy: Lessons from clinical trials. J. Mol. Cell. Cardiol. 50(2):258-265; 2011.
26. Mohamadnejad, M.; Alimoghaddam, K.; Mohyeddin-Bonab, M.; Bagheri, M.; Bashtar, M.; Ghanaati, H.; Baharvand, H.; Ghavamzadeh, A.; Malekzadeh, R. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch. Iran. Med. 10(4):459-466; 2007.
27. Mohyeddin-Bonab, M.; Mohamad-Hassani, M. R.; Alimoghaddam, K.; Sanatkar, M.; Gasemi, M.; Mirkhani, H.; Radmehr, H.; Salehi, M.; Eslami, M.; Farhig-Parsa, A.; Emami-Razavi, H.; Alemohammad, M. G.; Solimani, A. A.; Ghavamzadeh, A.; Nikbin, B. Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch. Iran. Med. 10(4):467- 473; 2007.
28. Moodley, Y.; Atienza, D.; Moodley, Y.;, Atienza, D.; Manuelpillai, U.; Samuel, C. S.; Tchongue, J.; Ilancheran, S.; Boyd, R.; Trounson, A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am. J. Pathol. 175(1):303-313; 2009.
29. Pal, R.; Hanwate, M.; Jan, M.; Totey, S. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J. Tissue Eng. Regen. Med. 3(3):163-174; 2009.
30. Pal, R.; Hanwate, M.; Totey, S. M. Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation. J. Tissue Eng. Regen. Med. 2(7):436-444; 2008.
31. Park, S. S.; Byeon, Y. E.; Ryu, H. H.; Kang, B. J.; Kim, Y.; Kim, W. H.; Kang, K. S.; Han, H. J.; Kweon, O. K. Comparison of canine umbilical cord blood-derived mesenchymal stem cell transplantation times: Involvement of astrogliosis, inflammation, intracellular actin cytoskeleton pathways, and neurotrophin. Cell Transplant. 20(11/ 12):1867-1880; 2011.
32. Sarugaser, R.; Lickorish, D.; Baksh, D.; Hosseini, M. M.; Davies, J. E. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23(2):220-229; 2005.
33. Seeger, F. H.; Tonn, T.; Krzossok, N.; Zeiher, A. M.; Dimmeler, S. Cell isolation procedures matter: A comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur. Heart J. 28(6):766-772; 2007.
34. Serigano, K.; Sakai, D.; Hiyama, A.; Tamura, F.; Tanaka, M.; Mochida, J. Effect of cell number on mesenchymal stem cell transplantation in a canine disc degeneration model. J. Orthop. Res. 28(10):1267-1275; 2010.
35. Song, H.; Cha, M. J.; Song, B. W.; Kim, I. K.; Chang, W.; Lim, S.; Choi, E. J.; Ham, O.; Lee, S. Y.; Chung, N.; Jang, Y.; Hwang, K. C. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 28(3):555-563; 2010.
36. Stolzing, A.; Coleman, N.; Scutt, A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res. 9(1):31-35; 2006.
37. Stolzing, A.; Jones, E.; McGonagle, D.; Scutt, A. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech. Ageing Dev. 129(3):163-173; 2008.
38. Sun, L.; Akiyama, K.; Zhang, H.; Yamaza, T.; Hou, Y.; Zhao, S.; Xu, T.; Le, A.; Shi, S. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6):1421-1432; 2009.
39. Troyer, D. L.; Weiss, M. L. Concise review: Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26(3):591-599; 2008.
40. Tsai, M. S; Hwang, S. M.; Chen, K. D.; Lee, Y. S.; Hsu, L. W.; Chang, Y. J.; Wang, C. N.; Peng, H. H.; Chang, Y. L.; Chao, A. S.; Chang, S. D.; Lee, K. D.; Wang, T. H.; Wang, H. S.; Soong, Y. K. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 25(10):2511-2523; 2007.
41. Venkataramana, N. K.; Kumar, S. K.; Balaraju, S.; Radhakrishnan, R. C.; Bansal, A.; Dixit, A.; Rao, D. K.; Das, M.; Jan, M.; Gupta, P. K.; Totey, S. M. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 155(2):62-70; 2010.
42. Wang, D.; Zhang, F.; Shen, W.; Chen, M.; Yang, B.; Zhang, Y.; Cao, K. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int. J. Cardiol. 152(3):314- 320; 2011.
43. Wang, Y.; Han, Z.; Yan, S.; Mao, A.; Wang, B.; Ren, H.; Chi, Y.; Han, Z. Evaluation of suitable reference gene for real-time PCR in human umbilical cord mesenchymal stem cells with long-term in vitro expansion. In Vitro Cell Dev. Biol. Anim. 46(7):595-599; 2010.
44. Weiss, M. L.; Medicetty, S.; Weiss, M. L.; Medicetty, S.; Bledsoe, A. R.; Rachakatla, R. S.; Choi, M.; Merchav, S.; Luo, Y.; Rao, M. S.; Velagaleti, G.; Troyer, D. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24(3):781-792; 2006.
45. Huang, J.; Chen, C.; Zhang, Z.; Jia, M.; Xiong, J.; Liu, X.; Wang, F.; Cao, X.; Liang, Z; Sun, S.; Lin, Z.; Wang, T. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther. 18(4):394-402; 2011.